Abstract：Objective To investigate the effect of Pramipexole combined with Compoud Levodopa on motor function and non-motor symptoms in patients with Parkinson′s disease (PD). Methods A total of 96 patients with PD admitted to the Third People′s Hospital of Dalian from June 2017 to May 2019 were selected as the research objects, they were divided into observation group and control group according to the random number table method, with 48 cases in each group. The control group received Compound Levodopa, the observation group received Compound Levodopa combined with Pramipexole, both for 16 weeks. The united Parkinson′s disease scale (UPDRS) Ⅲ, hamilton depression scale(HAMD), non motor symptoms and the total incidence of adverse reactions were compared between the two groups. Results Before treatment, there were no significant differences in UPDRSⅢ, HAMD scores, frequency of urination, urgency of urination, abnormal sensation, sleep disorder, salivation and constipation between the two groups (P＞0.05). After treatment, the scores of UPDRSⅢ, HAMD, frequency of urination, urgency of urination, abnormal sensation and sleep disorder in the observation group were lower than those in the control group, the differences were statistically significant (P＜0.05). The total incidence of adverse reactions in the observation group was 6.25%, which was lower than 20.83% in the control group, the difference was statistically significant (P＜0.05). Conclusion Pramipexole combined with Compound Levodopa can relieve anxiety of PD patients, reduce the incidence of non motor symptoms and adverse reactions, which is worthy of clinical application.
侯宇；周莹；娄伟；于敏. 普拉克索联合复方左旋多巴对帕金森病患者运动功能及非运动症状的影响[J]. 中国当代医药, 2020, 27(6): 69-72.
HOU Yu ZHOU Ying LOU Wei YU Min▲. Effect of Pramipexole combined with Compoud Levodopa on motor function and non-motor symptoms in patients with Parkinson′s disease. 中国当代医药, 2020, 27(6): 69-72.
京公网安备 11010502046607号